The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
10,876
Sort by:
Investigation Report on China Risedronate Sodium Market, 2010-2019
US$ 2,000.00
... Risedronate sodiums in the Chinese market are all produced by local enterprises represented by Kunming Jida Pharmaceutical Co., Ltd, Topfond, Yangtze River Pharmaceutical Group, Jiangsu Chiatai Qingjiang Pharmaceutical Co., Ltd and Beijing SL Pharm, among which Kunming Jida Pharmaceutical Co., Ltd ...
June 2015
30 pages
Investigation Report on China Thrombin Market, 2010-2019
US$ 2,000.00
... thrombin in the Chinese market are Changchun Guoao Pharmaceutical Co., Ltd, Biochemical Pharmaceutical Factory of Zhuhai S. E. Z., Hunan Yige Pharmaceutical Co., Ltd, Hacon Pharma and Wuxi Kaifu Pharmaceutical Co., Ltd ...
June 2015
35 pages
Investigation Report on China Piperacillin Sodium and Tazobactam Sodium Market, 2010-2019
US$ 2,000.00
... Wyeth Pharmaceutical Co., Ltd (US), Qilu Pharmaceutical Co., Ltd, North China Pharmaceutical Group Corporation, Zhejiang Anglikang Pharmaceutical Co., Ltd and United Laboratories occupy the majority of the Chinese market, among which Wyeth Pharmaceutical Co., Ltd ...
June 2015
35 pages
2015-2019 World Drugs of Abuse Testing Market: Country Forecasts, Innovative Technologies, Competitive Strategies--France, Germany, Italy, Japan, Spain, UK, US
US$ 6,800.00
... from VPGMarketResearch contains 68 tables and provides analysis of the global drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts ... products, such as specimen preparation devices, controls, calibrators and others. 2015 2019 World Drugs of Abuse Testing Market is a unique study designed to help current suppliers and ...
June 2015
318 pages
2015-2019 World Therapeutic Drug Monitoring (TDM) Market: Country Forecasts, Innovative Technologies, Competitive Strategies--France, Germany, Italy, Japan, Spain, UK, US
US$ 6,800.00
... from VPGMarketResearch contains 83 tables and provides analysis of the global therapeutic drug monitoring testing market, including emerging tests, technologies, instrumentation, sales forecasts ... products, such as specimen preparation devices, controls, calibrators and others. 2015 2019 World Therapeutic Drug Monitoring (TDM) Market is a unique worldwide market and technology assessment designed ...
June 2015
313 pages
2015-2019 European Therapeutic Drug Monitoring (TDM) Market: Country Forecasts, Innovative Technologies, Competitive Strategies--France, Germany, Italy, Spain, UK
US$ 5,200.00
... 291 page report from VPGMarketResearch provides a comprehensive analysis of the European therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market ... products, such as specimen preparation devices, controls, calibrators and others. 2015 2019 European Therapeutic Drug Monitoring (TDM) Market is a unique market and technology assessment designed to help ...
June 2015
291 pages
2015-2019 European Drugs of Abuse Testing Market: Country Forecasts, Innovative Technologies, Competitive Strategies--France, Germany, Italy, Spain, UK
US$ 5,200.00
... 300 page report from VPGMarketResearch provides a comprehensive analysis of the European drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts ... products, such as specimen preparation devices, controls, calibrators and others. 2015 2019 European Drugs of Abuse Testing Market” is a unique study designed to help current suppliers and ...
June 2015
300 pages
Investigation Report on China Bromhexine Market, 2010-2019
US$ 2,000.00
... bromhexine in the Chinese market mainly comes from local enterprises like Jiangxi Kelun Pharmaceutical Co., Ltd, Jincheng Haisi Pharmaceutical Co., Ltd and Shanxi Powerdone Pharmaceutical Co., Ltd, Shijiazhuang No.4 Pharmaceutical Co., Ltd ...
June 2015
30 pages
Investigation Report on China Entecavir Market, 2010-2019
US$ 2,000.00
... hepatitis B virus (HBV) exceeds 100 million in China, among which 20-30 million suffering from chronic Hepatitis B. ... entecavir in China rose from CNY 30 million in 2006 to CNY 1.207 billion in 2014 and CAGR during this period reached up to 55%. Entecavir made by Sino-American Shanghai Squibb Pharmaceuticals Ltd ...
June 2015
30 pages
Investigation Report on China Ganglioside Market, 2010-2019
US$ 2,000.00
... ganglioside sodium in China, among which Qilu Pharmaceutical Co., Ltd, Medical University Pharmaceutical Co., Ltd, Beijing Science Sun Pharmaceutical Co., Ltd, Changchun Xiangtong Pharmaceutical Co., Ltd and Wellso Pharmaceutical take the lion’s share. The marketing of domestic ganglioside ...
June 2015
35 pages
Investigation Report on China Glucosamine Market, 2010-2019
US$ 2,000.00
... Glucosamine is of great demand in China. Most of the market share has been occupied by Shanxi Zhongyuanwei Pharmaceutical Co., Ltd, Bright Future Pharmaceutical Laboratories Limited, Rottapharm Ltd, Zhejiang Hisun Pharmaceutical Co., Ltd ...
June 2015
35 pages
Investigation Report on China Levothyroxine Market, 2010-2019
US$ 2,000.00
... Thyroid hormones (TH) have the greatest effect of promoting growth on five-month-old babies or younger ones. Without thyroid hormones ... Levothyroxine enjoys a vast demand in China. Merck (Germany), Berlin-Chemie AG (Germany) and China Associated Pharmaceutical all take up certain market share, among which Merck ...
June 2015
20 pages
Investigation Report on China Menotropins Market, 2010-2019
US$ 2,000.00
... Livzon Pharmaceutical, Livzon Pharmaceutical Group, Inc, Ferring Pharmaceytical Co., Ltd (Germany), Ma’anshan Fengyuan Pharmaceutical Co., Ltd, Yantai North Pharmaceutical Co., Ltd and Shanghai Livzon Pharmaceutical Co., Ltd, among which Shanghai Livzon Pharmaceutical Co., Ltd ...
June 2015
30 pages
Investigation Report on China Moxifloxacin Market, 2010-2019
US$ 2,000.00
... China are mainly produced by Nanjing Youke Pharmaceutical CO., Ltd and The Bayer Group whichowns the larger market share of over 95% for sales value in 2014. As an outstanding antibacterial drug, moxifloxacin ...
June 2015
20 pages
Investigation Report on China Ossotide Market, 2010-2019
US$ 2,000.00
... of rheumatoid arthritis (RA) is 0.2%-0.36% and the number of cases is 5-10 million in China. Apart from RA, osteoarthritis, an expression of ... ossotide in China competitive landscape of ossotide in Chinese market price of ossotide made by different enterprises in China market outlook of ossotide in China ...
June 2015
35 pages
Investigation Report on China Progesterone Market, 2010-2019
US$ 2,000.00
... progesterone in the Chinese market is imported and made by Fleet (UK) and Capsugel(FR). The rest mainly comes from such local manufacturers as Asen, Zhejiang Xianju Pharmaceutical Co., Ltd ... steroid drugs will keep growing and that with the development of downstream products, the demand for progesterone ...
June 2015
35 pages
Investigation Report on China Rosuvastatin Market, 2010-2019
US$ 2,000.00
... rosuvastatin (rosuvastatin calcium ... rosuvastatin in the Chinese market mainly come from the following companies: IPR Pharmaceuticals (US), Lunan Better Pharmaceutical Co., Ltd, Nanjing Chia Tai Tianqing, Simcere and Zhejiang Jingxin Pharmaceutical Co., Ltd, among which IPR Pharmaceuticals ...
June 2015
35 pages
Investigation Report on China Atorvastatin Market, 2010-2019
US$ 2,000.00
... in the near future. Atorvastatin, a common drug that can lower blood cholesterol levels, was developed by Pfizer under the trade name of Lipitor. Boasting of nearly ... miracle among all the medicines for sale. After entering China, atorvastatin develops fast with annual sales value rising from less ...
June 2015
30 pages
Investigation Report on China Tacrolimus Market, 2010-2019
US$ 2,000.00
... Tacrolimus (also FK506) is a macrolide lactone immunosuppressive drug discovered from a soil sample that contained the bacterium Streptomyces tsukubaensis in 1984 by Fujisawa Pharmaceutical Co., Ltd. Tacrolimus ...
June 2015
30 pages
Investigation Report on China Insulin Lispro Market, 2010-2019
US$ 2,000.00
... : market size of insulin lispro in China market share of manufacturers of Insulin Lispro in China retail price of insulin lispro in Chinese market major manufacturers of insulin lispro in Chinese market market outlook of insulin lispro in China The author suggests ...
June 2015
20 pages
Investigation Report on China Capecitabine Market, 2010-2019
US$ 2,000.00
... name of Xeloda and then spread through over 80 countries and regions in 2 years. In Mar. 2001, capecitabine entered China to be clinically used for the treatment of advanced breast cancer, colorectal cancer and other solid tumors. The chemotherapy for colorectal cancer ...
June 2015
30 pages
Investigation Report on China Celecoxib Market, 2010-2019
US$ 2,000.00
... the market. In Sep. 2000, celebrex (celecoxib capsule) made by Pfizer Inc was approved by CFDA to enter China. Celecoxib develops fast then, ... celecoxib in Chinese market market outlook of celecoxib in China The author suggests the following groups of people purchase this report: manufacturers of NSAIDs ...
June 2015
20 pages
Investigation Report on China Desloratadine Market, 2010-2019
US$ 2,000.00
... desloratadine in China market share of manufacturers of desloratadine in China price of desloratadine in Chinese market major manufacturers of desloratadine in Chinese market market outlook of desloratadine in China ...
June 2015
30 pages
Investigation Report on China Doxofylline Market, 2010-2019
US$ 2,000.00
... doxofylline in China market share of manufacturers of doxofylline in China price of doxofylline in Chinese market major manufacturers of doxofylline in Chinese market market outlook of doxofylline in China ...
June 2015
30 pages
